Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

Since Wegovy is prescribed in higher doses, it can be more effective than Ozempic for weight loss. A 2022 systematic review and meta-analysis looked at eight studies with more than 4,500 participants.

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Insurers reported 91 per cent increase in claims for weight-loss drugs last year after Wegovy launched in Canada ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

A review of the plans and subsequent trades ... thousands of people who are unable to access brand-name weight-loss drugs including Wegovy. On Tuesday, Dudum said in a statement announcing ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...